PRDM1 is required for mantle cell lymphoma response to bortezomib.
about
Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGALGene selection using iterative feature elimination random forests for survival outcomes.Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7)Bortezomib for the treatment of non-Hodgkin's lymphomaGenomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleasesThe downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.Bortezomib: A Review in Mantle Cell Lymphoma in Previously Untreated Patients Unsuitable for Stem-Cell Transplantation.Computational Systems Biology Approach Predicts Regulators and Targets of microRNAs and Their Genomic Hotspots in Apoptosis Process.The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer.
P2860
Q34624167-21BB754C-4E08-4A0D-A385-026B69D9A5F1Q35152037-BA4E1450-4A8A-4C1D-848A-F0D3DE976683Q35172803-3B0F67E6-D77A-4059-8217-E9DD0DF9E18DQ36390465-C3086BB7-71EF-4F56-998A-5BE2A1800FF2Q36725008-DE2D4809-B84B-4896-AA82-939254511241Q36868056-88E2A382-2B5E-427C-983D-A48D87172583Q36915157-F305561E-E193-419E-B797-CC9D637BA405Q37504355-88451036-FAAC-4DF2-9636-FF81E8447109Q38538693-3FC73094-4205-4952-8827-5A404B1CD35CQ38771004-97C0A487-7430-4560-9414-0131EA794306Q39029195-DD480CB4-38AF-4F66-9043-A0007B55DACCQ47856794-080352D9-859E-4E02-B4C8-6AA374D297ECQ50911306-F5E661C2-A954-4B5B-82EA-7A6FB7606D53
P2860
PRDM1 is required for mantle cell lymphoma response to bortezomib.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@en
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@nl
type
label
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@en
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@nl
prefLabel
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@en
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@nl
P2093
P2860
P1476
PRDM1 is required for mantle cell lymphoma response to bortezomib.
@en
P2093
Eduardo Sotomayor
Jianguo Tao
Kenneth L Wright
Matthew A Smith
Michelle Maurin
Shruti Desai
Sophia C E Bolick
Sophie Dessureault
P2860
P304
P356
10.1158/1541-7786.MCR-10-0131
P577
2010-06-08T00:00:00Z